ArticleCytotechnology1998

Apoptosis-resistant NS/0 E1B-19K myelomas exhibit increased viability and chimeric antibody productivity under cell cycle modulating conditions.

S Mercille et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.